Focus on Advanced NSCLC: Expert Insights and Strategies for Refining Patient Care
  • Program Overview
    Focus on Advanced NSCLC: Expert Insights and Strategies for Refining Patient Care
    Explore key issues in the management of advanced NSCLC in this educational program designed to keep you abreast of rapidly evolving treatment practices. Gain expert insights on new developments as they emerge with the CME/CE-certified interactive modules, short expert commentaries, and the Interactive Decision Support Tool that will let you compare your treatment choices for specific patient scenarios in advanced NSCLC with those of 5 experts.
  • Featured content
    Download this checklist resource as a guide for important discussion points to have during your consultations with patients with advanced NSCLC and their caregivers.
    Date Posted: 1/25/2017
  • Featured content
    In this interactive, CME/CE-certified module, Alice Shaw, MD, PhD, provides her perspective on optimizing treatment strategies for advanced-stage ALK and ROS1 rearrangement–positive NSCLC.
  • Checkpoint inhibitor therapy is now approved for newly diagnosed metastatic NSCLC. Naiyer Rizvi, MD, discusses the latest clinical data from ESMO 2016 supporting this landmark change in advanced NSCLC management.
    Date Posted: 10/27/2016
  • Featured content
    In this interactive, CME/CE-certified module, Suresh S. Ramalingam, MD, provides expert perspective on optimizing treatment strategies for advanced-stage squamous NSCLC.
  • 1
  • 2
  • 3
  • 4
  • 5

Latest Content

10 of 12 Shown
10 of 12 Shown
Show 2 More
Loading...